Purchase Order SPE2DP25P0664
- Not listed
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a firm fixed price purchase order valued at $10,585.32 to Eagle Pharmaceuticals, Inc. for Dantrolene Sodium F, with performance expected to conclude by September 19, 2025. This contract is designated as a Total Small Business set-aside and was awarded on September 4, 2025, with work to be performed in Westwood, New Jersey. Eagle Pharmaceuticals, a specialized pharmaceutical manufacturer headquartered in...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $10,585.32 firm fixed-price purchase order to Eagle Pharmaceuticals, Inc. for Dantrolene Sodium F on September 4, 2025. The contract, designated as a Total Small Business set-aside, has an ultimate completion date of September 19, 2025 and will be performed in Westwood, New Jersey. Eagle Pharmaceuticals, a specialized pharmaceutical manufacturer headquartered in Woodcliff Lake, New Jersey, has established itself...
- The U.S. Department of Defense Medical Supply Chain has awarded a $10,585.32 firm fixed-price purchase order to Eagle Pharmaceuticals, Inc. for Dantrolene Sodium F, a critical injectable medication. The contract, designated as a Total Small Business set-aside, was awarded on September 3, 2025, with an ultimate completion date of September 18, 2025. Performance will take place in Westwood, New Jersey. Eagle Pharmaceuticals, a specialized pharmaceutical manufacturer headquartered in Woodcliff...
- This federal contract award, valued at $58,219.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, for the supply of Dantrolene Sodium F medication. The contract has a total small business set-aside designation. The original solicitation, which was posted on March 27, 2025 and had a due date of April 2, 2025, requested the procurement of 33 units of Dantrolene Sodium F medication across 11 line...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,292.66 by the Defense Logistics Agency's Medical Supply Chain for the supply of Dantrolene Sodium Powder. The contract, issued on February 28, 2025, carries an ultimate completion date of March 21, 2025, and represents a firm fixed-price arrangement with no set-aside designation. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Medical Supply Chain for the supply of Fosphenytoin 500 mg PE/10 mL (10 mL vials) with a ceiling value of $1,189.39. This firm fixed-price delivery order is not set-aside and is scheduled for ultimate completion by September 10, 2025. The award represents a routine pharmaceutical procurement fulfilling federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Diazepam 50 mg/10 mL vials with a ceiling value of $1,908.34 and completion deadline of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Sodium Phenylacetate-Sodium Benzoate VL 50ML with a ceiling value of $16,121.40 and a firm fixed price structure. The order is due for completion by September 2, 2025, and represents a non-competitive, non-set-aside award executed under the company's existing contract vehicle. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $3,785.17 delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of Ebiglasss 250 mg/2 ml pens with a completion date of May 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $1,563.95 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Dyanavel XR 2.5 mg/mL suspension (464 mL). This is a firm fixed price, non-set-aside contract with a completion date of July 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor...
Eagle Pharmaceuticals, Inc. was awarded a firm fixed price purchase order valued at $5,292.66 for Dantrolene Sodium on September 17, 2025, with an ultimate completion date of September 22, 2025. The contract, which carries no set-aside designation, is funded by the Defense Department's Medical Supply Chain and will be performed in Westwood, New Jersey. As a specialized pharmaceutical manufacturer headquartered in Woodcliff Lake, New Jersey, Eagle Pharmaceuticals has established itself as a critical supplier of injectable medications to federal agencies, particularly the Department of Defense and Department of Veterans Affairs. This purchase order represents a continuation of Eagle Pharmaceuticals' ongoing role in supporting federal medical readiness through the supply of specialized pharmaceutical products. The company maintains a significant Federal Supply Schedule contract with the VA Veterans Health Administration valued at $30.9 million through January 2029, which enables efficient procurement of pharmaceutical and drug products across multiple government entities including the Defense Logistics Agency. Dantrolene sodium, commonly used in medical applications including the treatment of malignant hyperthermia, aligns with Eagle Pharmaceuticals' core business of providing critical injectable medications essential to military and veterans' healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 9/17/25 |